BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Shionogi & Co., Ltd. 

1-8, Doshomachi 3-Chome
Chuo-ku
Osaka     541-0045  Japan
Phone: 81-0-6-6202-2161 Fax: 81-0-6-6229-9596


SEARCH JOBS



Segment
Research





 Company News
GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test 7/11/2012 6:44:43 AM    More...
Shionogi & Co., Ltd. and Shionogi, Inc. Announce a Favorable Decision In FORTAMET® Preliminary Injunction Proceedings 12/7/2011 8:43:56 AM    More...
Shire plc Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd. 11/18/2011 10:38:15 AM    More...
MorphoSys AG and Shionogi & Co., Ltd. Agree Three-Year Extension of Research Partnership 11/2/2011 8:37:48 AM    More...
Evotec AG (EVTG.F) Achieves Two Milestones in Fragment-based Drug Discovery Alliance With Shionogi & Co., Ltd. 10/27/2011 10:16:12 AM    More...
Japan's Shionogi & Co., Ltd. to Acquire C&O Pharmaceutical Technology for About $182 Million 8/1/2011 8:05:28 AM    More...
Shionogi & Co., Ltd. Announces Commercial Availability of CUVPOSA(TM) (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 4/7/2011 6:31:09 AM    More...
Graffinity Pharmaceuticals GmbH Enters into Drug Discovery Collaboration with Shionogi & Co., Ltd. 3/30/2011 9:22:32 AM    More...
Biocryst Pharmaceuticals (BCRX)'s Partner Shionogi & Co., Ltd. Receives Approval for Pediatric Use Of Flu Drug Peramivir in Japan 10/27/2010 8:23:35 AM    More...
Shionogi & Co., Ltd. Announces Reorganization of US Operations, New Leadership; New CEO Named 7/1/2010 11:28:36 AM    More...
123456

//-->